Literature DB >> 18386173

Programmed cell death 4 inhibits breast cancer cell invasion by increasing tissue inhibitor of metalloproteinases-2 expression.

René Nieves-Alicea1, Nancy H Colburn, Ann-Marie Simeone, Ana M Tari.   

Abstract

High levels of the cyclooxygenase-2 (COX-2) protein have been associated with invasion and metastasis of breast tumors. Both prostaglandin E(2) (PGE(2)) and interleukin-8 (IL-8) have been shown to mediate the invasive activity of COX-2 in breast cancer cells. Here we expand these studies to determine how COX-2 uses PGE(2) and IL-8 to induce breast cancer cell invasion. We demonstrated that PGE(2) and IL-8 decreased the expression of the tumor suppressor protein Programmed Cell Death 4 (PDCD4). We hypothesized that suppression of PDCD4 expression is vital to the invasive activity of PGE(2) and IL-8. In MCF-7 cells overexpressing PDCD4 (MCF-7/PDCD4), PGE(2) and IL-8 failed to induce invasion, in contrast to the parental MCF-7 cells, thus indicating that PDCD4 blocks breast cancer cell invasion. MCF-7/PDCD4 cells produced higher levels of the Tissue Inhibitor of Metalloproteinases-2 (TIMP-2) than the parental cells. Silencing TIMP-2 mRNA in MCF-7/PDCD4 cells reversed the anti-invasive effects of PDCD4, allowing PGE(2) and IL-8 to induce the invasion of these cells. Here we report the novel findings that suppression of PDCD4 expression is vital for the invasive activity of COX-2 mediated by PGE(2) and IL-8, and that PDCD4 increases TIMP-2 expression to inhibit breast cancer cell invasion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18386173      PMCID: PMC2635917          DOI: 10.1007/s10549-008-9993-5

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  33 in total

1.  The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation.

Authors:  Hsin-Sheng Yang; Aaron P Jansen; Anton A Komar; Xiaojing Zheng; William C Merrick; Sylvain Costes; Stephen J Lockett; Nahum Sonenberg; Nancy H Colburn
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

2.  Systemic gene therapy with anti-angiogenic factors inhibits spontaneous breast tumor growth and metastasis in MMTVneu transgenic mice.

Authors:  M G Sacco; E M Catò; R Ceruti; S Soldati; S Indraccolo; M Caniatti; E Scanziani; P Vezzoni
Journal:  Gene Ther       Date:  2001-01       Impact factor: 5.250

3.  Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation.

Authors:  J L Cmarik; H Min; G Hegamyer; S Zhan; M Kulesz-Martin; H Yoshinaga; S Matsuhashi; N H Colburn
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

4.  A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation.

Authors:  H S Yang; A P Jansen; R Nair; K Shibahara; A K Verma; J L Cmarik; N H Colburn
Journal:  Oncogene       Date:  2001-02-08       Impact factor: 9.867

5.  Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitor.

Authors:  Z Zhang; R N DuBois
Journal:  Oncogene       Date:  2001-07-27       Impact factor: 9.867

Review 6.  Complex roles of tissue inhibitors of metalloproteinases in cancer.

Authors:  Yangfu Jiang; Itzhak D Goldberg; Y Eric Shi
Journal:  Oncogene       Date:  2002-03-28       Impact factor: 9.867

7.  Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer.

Authors:  Ari Ristimäki; Anna Sivula; Johan Lundin; Mikael Lundin; Tiina Salminen; Caj Haglund; Heikki Joensuu; Jorma Isola
Journal:  Cancer Res       Date:  2002-02-01       Impact factor: 12.701

8.  Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma.

Authors:  Carsten Denkert; Klaus-Jürgen Winzer; Berit-Maria Müller; Wilko Weichert; Sören Pest; Martin Köbel; Glen Kristiansen; Angela Reles; Antje Siegert; Hans Guski; Steffen Hauptmann
Journal:  Cancer       Date:  2003-06-15       Impact factor: 6.860

9.  Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis.

Authors:  Yuan Chen; Thomas Knösel; Glen Kristiansen; Agnieszka Pietas; Mitchell E Garber; Sachiko Matsuhashi; Iwata Ozaki; Iver Petersen
Journal:  J Pathol       Date:  2003-08       Impact factor: 7.996

10.  MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer.

Authors:  I A Asangani; S A K Rasheed; D A Nikolova; J H Leupold; N H Colburn; S Post; H Allgayer
Journal:  Oncogene       Date:  2007-10-29       Impact factor: 9.867

View more
  26 in total

1.  Pdcd4 knockdown up-regulates MAP4K1 expression and activation of AP-1 dependent transcription through c-Myc.

Authors:  Qing Wang; Yan Zhang; Hsin-Sheng Yang
Journal:  Biochim Biophys Acta       Date:  2012-07-16

2.  AKT Activation by Pdcd4 Knockdown Up-Regulates Cyclin D1 Expression and Promotes Cell Proliferation.

Authors:  Xiaoling Guo; Wenjuan Li; Qing Wang; Hsin-Sheng Yang
Journal:  Genes Cancer       Date:  2011-08

3.  Downregulation of programmed cell death 4 (PDCD4) in tumorigenesis and progression of human digestive tract cancers.

Authors:  Gang Ma; Hao Zhang; Ming Dong; Xinyu Zheng; Iwata Ozaki; Sachiko Matsuhashi; Kejian Guo
Journal:  Tumour Biol       Date:  2013-07-10

Review 4.  The role of Pdcd4 in tumour suppression and protein translation.

Authors:  Qing Wang; Hsin-Sheng Yang
Journal:  Biol Cell       Date:  2018-05-28       Impact factor: 4.458

5.  LRRC75A-AS1 targets miR-199b-5p/PDCD4 axis to repress multiple myeloma.

Authors:  Quantang Pang; Yanyan Wang; Dapeng Bi; Hongyu Lu
Journal:  Cancer Biol Ther       Date:  2020-11-01       Impact factor: 4.742

6.  Development of a high-throughput cell-based reporter assay to identify stabilizers of tumor suppressor Pdcd4.

Authors:  Johanna S Blees; Tobias Schmid; Cheryl L Thomas; Alyson R Baker; Lauren Benson; Jason R Evans; Ekaterina I Goncharova; Nancy H Colburn; James B McMahon; Curtis J Henrich
Journal:  J Biomol Screen       Date:  2009-11-09

7.  Programmed cell death 4 (PDCD4) expression during multistep Barrett's carcinogenesis.

Authors:  Matteo Fassan; Marco Pizzi; Giorgio Battaglia; Luciano Giacomelli; Paola Parente; Paolo Bocus; Ermanno Ancona; Massimo Rugge
Journal:  J Clin Pathol       Date:  2010-08       Impact factor: 3.411

8.  Down-regulation of programmed cell death 4 leads to epithelial to mesenchymal transition and promotes metastasis in mice.

Authors:  Qing Wang; Jiang Zhu; Yong Zhang; Zhenxiao Sun; Xiaoling Guo; Xin Wang; Eun Lee; Vasudevan Bakthavatchalu; Qifeng Yang; Hsin-Sheng Yang
Journal:  Eur J Cancer       Date:  2013-01-10       Impact factor: 9.162

9.  PDCD4 expression in thyroid neoplasia.

Authors:  Gianmaria Pennelli; Matteo Fassan; Caterina Mian; Marco Pizzi; Mariangela Balistreri; Susi Barollo; Francesca Galuppini; Vincenza Guzzardo; Mariarosa Pelizzo; Massimo Rugge
Journal:  Virchows Arch       Date:  2012-12-05       Impact factor: 4.064

10.  Downregulation of microRNA-182 inhibits cell growth and invasion by targeting programmed cell death 4 in human lung adenocarcinoma cells.

Authors:  Min Wang; Yuanyuan Wang; Wenqiao Zang; Huaqi Wang; Heying Chu; Ping Li; Min Li; Guojun Zhang; Guoqiang Zhao
Journal:  Tumour Biol       Date:  2013-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.